Evidence map›Paper›PMID 29534436›Full record

ArticleViruses2018

"French Phage Network"-Third Meeting Report.

Mireille Ansaldi, Laurent Debarbieux, Sylvain Gandon, Marie-Agnès Petit, Paulo Tavares, Pascale Boulanger

Open access · goldAbstract readConference Proceedings
In one paragraph

Article in Viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy ofProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Mireille AnsaldiLaboratoire de Chimie Bactérienne, UMR 7283 CNRS, Aix-Marseille Université, Institut de Microbiologie de la Méditerranée, 13402 Marseille, France. mireille.ansaldi@imm.cnrs.fr.ORCID 0000-0002-2878-0702
Laurent DebarbieuxDepartment of Microbiology, Institut Pasteur, 75015 Paris, France. laurent.debarbieux@pasteur.fr.ORCID 0000-0001-6875-5758
Sylvain GandonCentre d'Ecologie Fonctionnelle et Evolutive (CEFE)-UMR 5175, CNRS, Université de Montpellier, 34293 Montpellier, France. sylvain.gandon@cefe.cnrs.fr.
Marie-Agnès PetitMicalis Institute, INRA, AgroParisTech, Université Paris-Saclay, 78350 Jouy-en-Josas, France. marie-agnes.petit@inra.fr.
Paulo TavaresInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Sud, Université Paris-Saclay, 91190 Gif-sur-Yvette CEDEX, France. paulo.tavares@i2bc.paris-saclay.fr.
Pascale BoulangerInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Sud, Université Paris-Saclay, 91190 Gif-sur-Yvette CEDEX, France. pascale.boulanger@i2bc.paris-saclay.fr.
Centre National de la Recherche Scientifique · FRUniversité Paris-Sud · FRAgroParisTech · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In its third year of existence, the French Phage Network (Phages.fr) is pursuing its expansion. With more than 25 groups, mostly based in France, working on the various aspects of phage research, the network has increased its visibility, interactivity, and activity. The third meeting of the Phages.fr network, held on November 2017 at the Gif-sur-Yvette Centre National de la Recherche Scientifique (CNRS) campus, was a great opportunity for many young scientists to present their work and interact with more senior scientists, amongst which several were invited from abroad. Here we provide a summary of the work presented at this occasion during the oral presentations and poster sessions.

Indexed as

Biological EvolutionBiotechnologyHost-Pathogen InteractionsPhage TherapyBacteriophagesFrancebacteriabacteriophageco-evolutionFrancegenomicsinfectionphage therapyresistancestructural biologyvirulence

Identifiers

PMID29534436
PMCPMC5869516
OpenAlexW2791142155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.